{"organizations": [], "uuid": "ad0500e471ce34543f831cdb69ce16b30b581e12", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180119.html", "section_title": "Archive News &amp; Video for Friday, 19 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-bb-biotech-to-propose-330-sfr-divi/brief-bb-biotech-to-propose-3-30-sfr-dividend-for-2017-idUSFWN1PD1IE", "country": "US", "domain_rank": 408, "title": "BRIEF-BB Biotech to propose 3.30 Sfr dividend for 2017", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-19T14:05:00.000+02:00", "replies_count": 0, "uuid": "ad0500e471ce34543f831cdb69ce16b30b581e12"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-bb-biotech-to-propose-330-sfr-divi/brief-bb-biotech-to-propose-3-30-sfr-dividend-for-2017-idUSFWN1PD1IE", "ord_in_thread": 0, "title": "BRIEF-BB Biotech to propose 3.30 Sfr dividend for 2017", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "bb biotech ag", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 19 (Reuters) - BB Biotech AG:\n* SHOWS A DOUBLE-DIGIT TOTAL RETURN FOR 2017 - MID CAPS OVERDELIVER ON INNOVATION AND ARE BECOMING A KEY UPSIDE TRIGGER\n* ‍UNDERLYING PORTFOLIO PERFORMED WELL, ENDING YEAR UP 23.4% IN CHF, 12.5% IN EUR AND 29.2% IN USD​\n* ‍FULL YEAR 2017 DATA SHOWED A NET GAIN OF CHF 688 MN COMPARED TO A NET LOSS OF CHF 802 MN FOR FULL YEAR 2016​\n* ‍WILL PROPOSE A RECORD REGULAR DIVIDEND OF CHF 3.30 PER SHARE AT GENERAL ASSEMBLY ON MARCH 13, 2018​\n* ‍BELIEVES THAT 2018 WILL CONTINUE TO BRING IMPORTANT PRODUCT APPROVALS AND MILESTONES FOR SECTOR AND FOR ITS PORTFOLIO​ Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-19T14:05:00.000+02:00", "crawled": "2018-01-20T17:41:02.008+02:00", "highlightTitle": ""}